Mebendazole, an old Vermifuge – as an Adjuvant in Tumor Therapy
The proven vermifuge Mebendazole (Vermox) has appeared to be an excellent universal anti-cancer adjuvant in recent years. Since our meeting with Dr. Simon YU in our clinic and his impressing book “Accidental Blow up in medicine”, we were able to gain impressive experience.
How does Mebendazole work, what is known so far? It
intensifies chemo & radiation p especially with triple neg. breast cancer
blocks metastasis
activates killer cells and M1 MAFs, (M1 macrophages)
can slow acute leukemia
slows down glioblastoma, including meningioma
has shown effectiveness in melanoma
blocks the chemo resistance gene
Since modern kinase inhibitors, like checkpoint inhibitors, have little long-term effect, in creasingly existing drugs are being examined for “repurposing” – for effects against cancer. We have already reported on this elsewhere. Ivermectin, another vermifuge, is also a very safe agent and can inhibit tumor stem cells and intervenes in cancer metabolism with various interesting mechanisms.
The dosage is 100 mg Mebendazole (Vermox) daily for 3 weeks, then 1 week break before starting again.
https://www.st-george-hospital.com/mebendazole-an-old-vermifuge-as-an-adjuvant-in-tumor-therapy/